Literature DB >> 26835332

Advances in the medical research and clinical applications on the plasma DNA.

Shuye Wang1, Yuanyuan Chen1, Zhanhe Wu1.   

Abstract

Plasma DNA has had a strong impact and influence on basic medical research and clinical practice since the discovery of low levels of plasma DNA in healthy individuals under different physiological conditions. Although the source of circulating DNA still requires further investigation, a wide range of research has also proven the value of qualitative and quantitative measurements of plasma DNA in many disease conditions. The use of plasma DNA has a biomarker is advantageous due to accessibility, reliability, reproducibility, sensitivity, specific and relatively low cost. Recently, the detection of circulating (plasma) DNA quantitative changes have been using in the studies on the tumor gene mutations and to monitor disease progressing and to predict the disease prognosis. Such technique also has been using other many different fields, particularly in prenatal diagnosis, for which plasma DNA testing is preferable due to non-invasiveness. This article reviews the research progression and clinical applications of plasma DNA in the last several years.

Entities:  

Keywords:  Plasma DNA; haematological malignancies; non-invasive tool at diagnosis

Year:  2014        PMID: 26835332      PMCID: PMC4729110          DOI: 10.3978/j.issn.2224-4336.2014.03.07

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  37 in total

1.  Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Eleanore Lambley; Jacqueline Burrows; Ujjwal Dua; Suzanne Elliott; Peter J Shaw; H Miles Prince; Max Wolf; Kerrie Clarke; Craig Underhill; Tony Mills; Peter Mollee; Devinder Gill; Paula Marlton; John F Seymour; Rajiv Khanna
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

2.  Cell-free DNA in the plasma of patients with systemic sclerosis.

Authors:  Marta Mosca; Tiziana Giuliano; Giovanna Cuomo; Marica Doveri; Chiara Tani; Michele Curcio; Giuseppina Abignano; Francesca De Feo; Laura Bazzichi; Alessandra Della Rossa; Gabriele Valentini; Stefano Bombardieri
Journal:  Clin Rheumatol       Date:  2009-08-11       Impact factor: 2.980

3.  Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.

Authors:  Nobutoshi Hagiwara; Leah E Mechanic; Glenwood E Trivers; Helen L Cawley; Masataka Taga; Elise D Bowman; Kensuke Kumamoto; Peijun He; Mark Bernard; Saira Doja; Masao Miyashita; Takashi Tajiri; Koji Sasajima; Tsutomu Nomura; Hiroshi Makino; Ken Takahashi; S Perwez Hussain; Curtis C Harris
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  [Dynamic monitoring of plasma circulating DNA in patients with acute myeloid leukemia and its clinical significance].

Authors:  Ye Jiang; Shi-Yang Pan; Wen-Ying Xia; Dan Chen; Hong Wang; Li-Xia Zhang; Juan Xu; Ying Peng; Hai-Rong Qiu; Kou-Rong Miao; Jian-Yong Li; Yu-Jie Wu
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2012-02

5.  Better detection of Ig heavy chain and TCRγ gene rearrangement in plasma cell-free DNA from patients with non-Hodgkin Lymphoma.

Authors:  L Zhong; W F Huang
Journal:  Neoplasma       Date:  2010       Impact factor: 2.575

6.  The detection of oesophageal adenocarcinoma by serum microsatellite analysis.

Authors:  C F Eisenberger; N H Stoecklein; S Jazra; S B Hosch; M Peiper; P Scheunemann; J Schulte Am Esch; W T Knoefel
Journal:  Eur J Surg Oncol       Date:  2006-04-03       Impact factor: 4.424

7.  Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Authors:  K C Allen Chan; Jun Zhang; Anthony T C Chan; Kenny I K Lei; Sing-Fai Leung; Lisa Y S Chan; Katherine C K Chow; Y M Dennis Lo
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.

Authors:  K C Allen Chan; Paul B S Lai; Tony S K Mok; Henry L Y Chan; Chunming Ding; S W Yeung; Y M Dennis Lo
Journal:  Clin Chem       Date:  2008-07-24       Impact factor: 8.327

9.  Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.

Authors:  S Hohaus; M Giachelia; G Massini; G Mansueto; B Vannata; V Bozzoli; M Criscuolo; F D'Alò; M Martini; L M Larocca; M T Voso; G Leone
Journal:  Ann Oncol       Date:  2009-05-22       Impact factor: 32.976

10.  IgH gene rearrangements as plasma biomarkers in Non- Hodgkin's lymphoma patients.

Authors:  Jian He; Jian Wu; Yuchen Jiao; Nina Wagner-Johnston; Richard F Ambinder; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Oncotarget       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.